Nick Tait is the Chief Financial Officer of RxCelerate and Non-Executive Director of Cambridge Healthcare Research. He is responsible for the company’s financial health. As a managing director of Cambridge Partnership subsidiary, Nick provides the finance, investor relations, and administrative function for many virtual biotech companies. He has over 25 years’ experience in a wide range of financial roles.

Nick was educated in Cambridge at the Perse school, and graduated from the University of Warwick with a degree in Economics. He is a Fellow of the Institute of Chartered Accountants, having trained at EY in London.